FDA Inspection 849512 — Catalent Ontario Limited
The FDA completed an inspection of Catalent Ontario Limited on September 6, 2013 in Windsor. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 6, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Windsor (Canada)